Streetbeat News

Partnerships

ENLT

Enlight Renewable Energy (NASDAQ:ENLT) and Electra Power have signed a memorandum of understanding to form a joint venture to supply clean energy to residential consumers and small businesses in Israel. The Israeli electricity market will open to competition in January 2024, allowing independent suppliers and distributors of energy to compete with the incumbent Israeli Electricity Company. Electra Power will hold a 65% stake in the joint venture, with Enlight owning the remaining 35%. The establishment of the partnership is subject to regulatory approval.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:45 pm

OMQS

OMNIQ Corp. (NASDAQ:OMQS) has received an initial purchase order from the Israel Train Company to deploy its AI-based Machine Vision system at three key train stations. The system uses AI to generate dynamic 'heat maps' of passenger density and observes passenger behavior to enhance safety and comfort. The company sees potential for the system to be installed in train and subway stations worldwide.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:43 pm

NYSEAM:FOXO

FOXO Technologies Inc. has announced a partnership with Atrio Insurance/Singular Insurance Brokerage. This agreement will allow FOXO to expand its distribution footprint through Atrio/Singular's sales network of over 2,500 agents across 48 states. The partnership aims to drive innovation and deliver exceptional value to agents, brokers, and clients in the Insurance and Insurtech industries.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:41 pm

PAVS

Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) has signed a non-binding Letter of Intent to acquire BlueLine Studios Inc., a video game developer, for approximately $3.2 million in cash and unregistered Class A ordinary shares. The deal is expected to close in Q4 2023, subject to approvals and financing. The acquisition is part of Paranovus's strategic shift towards AI-powered online entertainment. BlueLine Studios, known for its AI-powered games, will focus on the development of the Hollywood Sunshine project post-acquisition.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:36 pm

XPOF

Xponential Fitness, Inc. (NYSE:XPOF) has issued its three-year operating targets ahead of its inaugural Analyst and Investor Day at the NYSE. The targets include 500 new studio openings, system-wide sales of $2.33 billion, revenue of $405 million, and adjusted EBITDA of $190 million. The company also announced a new partnership with Gympass and welcomed VaynerMedia as its official advertising agency.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:34 pm

AAPL

SFTBF

TSM

Apple Inc has signed a long-term deal with British chip designer Arm Ltd for chip technology that extends beyond 2040. Arm, backed by Softbank Group Corp, plans a $52 billion U.S. IPO in 2023. Apple uses Arm's technology to design custom chips for its devices. Taiwan Semiconductor Manufacturing Company Ltd, a leading contract chip maker and Apple supplier, is considering investing in Arm's IPO.

Portfolio Pulse from Anusuya Lahiri

September 06, 2023 | 12:31 pm

DIS

The Walt Disney Company (NYSE:DIS) has intervened in a cable blackout crisis during a dispute with Charter Communications, ensuring the broadcast of the U.S. Open tennis matches. Approximately 15 million U.S. pay-TV customers were unable to access Disney networks, including ESPN, due to a fee dispute with Charter. This comes amidst reports of Disney's restructuring and a potential sale of its ESPN cable sports channel.

Portfolio Pulse from Ramakrishnan M

September 06, 2023 | 12:25 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) and PathoQuest SAS have published a study validating their Next Generation Sequencing (NGS) viral safety assay as a reliable alternative to animal testing methods. The study demonstrated that the NGS-based assay had a greater capability of detecting viral contaminants compared to in vivo assays. The results support the use of the evaluated NGS-based transcriptomic assay as a superior alternative to current in vivo testing methods and aligns with the proposed ICH Q5A(R2) guidelines which are anticipated to be finalized and implemented by the end of 2023.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:20 pm

VBIV

VBI Vaccines Inc. (NASDAQ:VBIV) and its partner Brii Biosciences announced positive interim results from a Phase 2 study of BRII-179 (VBI-2601), a treatment for chronic hepatitis B. The treatment, in combination with PEG-IFNα, showed increased HBsAg loss rate and a significantly increased seroconversion rate. The safety findings were similar to previous reports. In 2023, VBI and Brii Bio expanded their partnership to include an exclusive global license to develop and commercialize BRII-179 and an exclusive license for VBI's prophylactic 3-antigen adult HBV vaccine in the Asia Pacific region, excluding Japan.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:19 pm

VCYT

Veracyte and Gustave Roussy have announced a collaboration aimed at helping biopharmaceutical companies accelerate the development of novel cancer therapies. The partnership will leverage Veracyte's genomic testing capabilities to identify potential therapeutic targets.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:16 pm